Platinum complexes act as shielding agents against virus infection

Area of Science:

• Inorganic Chemistry
• Virology
• Drug Development

Background:

• Viral infections pose significant public health challenges.
• Developing novel antiviral agents is crucial for combating emerging and re-emerging viruses.
• Platinum complexes have shown promise in various therapeutic areas, including antiviral applications.

Purpose of the Study:

• To investigate the antiviral potential of the substitution-inert polynuclear platinum complex (PPC), TriplatinNC.
• To elucidate the mechanism by which TriplatinNC protects cells against viral infections.
• To explore the feasibility of metalloshielding strategies for antiviral drug development.

Main Methods:

• Cell culture models were used to assess the antiviral activity of TriplatinNC against Enterovirus 71 and Human Metapneumovirus.
• Adduct formation between TriplatinNC and cell-surface glycosaminoglycans was analyzed.
• Mechanistic studies were performed to understand the inhibition of viral entry.

Main Results:

• TriplatinNC demonstrated significant protection against Enterovirus 71 and Human Metapneumovirus infections.
• The antiviral effect was attributed to the formation of adducts between TriplatinNC and cell-surface glycosaminoglycans.
• TriplatinNC was found to block viral entry by shielding host cells from viral attack.

Conclusions:

• TriplatinNC exhibits potent antiviral activity against specific RNA viruses.
• The mechanism of action involves the modification of cell-surface glycosaminoglycans, preventing viral attachment or entry.
• This study highlights the potential of polynuclear platinum complexes as a novel class of antiviral drugs utilizing a metalloshielding approach.